SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001745020-23-000009
Filing Date
2023-05-11
Accepted
2023-05-11 07:12:20
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q thrx-20230331.htm   iXBRL 10-Q 960453
2 EX-31.1 thrx-20230331xexx311.htm EX-31.1 10671
3 EX-31.2 thrx-20230331xexx312.htm EX-31.2 10652
4 EX-32.1 thrx-20230331xexx321.htm EX-32.1 5161
5 EX-32.2 thrx-20230331xexx322.htm EX-32.2 5144
  Complete submission text file 0001745020-23-000009.txt   4789584

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrx-20230331.xsd EX-101.SCH 31018
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrx-20230331_cal.xml EX-101.CAL 49965
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrx-20230331_def.xml EX-101.DEF 109075
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT thrx-20230331_lab.xml EX-101.LAB 421820
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrx-20230331_pre.xml EX-101.PRE 263579
57 EXTRACTED XBRL INSTANCE DOCUMENT thrx-20230331_htm.xml XML 782995
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40869 | Film No.: 23908786
SIC: 2834 Pharmaceutical Preparations